Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients

por Panse, J, Friedrichs, K, Marx, A, Hildebrandt, Y, Luetkens, T, Bartels, K, Horn, C, Stahl, T, Cao, Y, Milde-Langosch, K, Niendorf, A, Kröger, N, Wenzel, S, Leuwer, R, Bokemeyer, C, Hegewisch-Becker, S, Atanackovic, D
Publicado 2008

Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer

por Schønnemann, K R, Jensen, H A, Yilmaz, M, Jensen, B V, Larsen, O, Pfeiffer, P
Publicado 2008

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics

por Kristiansen, G, Fritzsche, F R, Wassermann, K, Jäger, C, Tölle, A, Lein, M, Stephan, C, Jung, K, Pilarsky, C, Dietel, M, Moch, H
Publicado 2008

Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer

por Rao, S, Starling, N, Cunningham, D, Benson, M, Wotherspoon, A, Lüpfert, C, Kurek, R, Oates, J, Baselga, J, Hill, A
Publicado 2008

A randomised phase II trial of preoperative chemotherapy of cisplatin–docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical...

por Kunitoh, H, Kato, H, Tsuboi, M, Asamura, H, Tada, H, Nagai, K, Mitsudomi, T, Koike, T, Nakagawa, K, Ichinose, Y, Okada, M, Shibata, T, Saijo, N
Publicado 2008

Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma

por Tabori, U, Wong, V, Ma, J, Shago, M, Alon, N, Rutka, J, Bouffet, E, Bartels, U, Malkin, D, Hawkins, C
Publicado 2008

Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion

por Lambert, L A, Whyteside, A R, Turner, A J, Usmani, B A
Publicado 2008

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients

por Aubele, M, Walch, A K, Ludyga, N, Braselmann, H, Atkinson, M J, Luber, B, Auer, G, Tapio, S, Cooke, T, Bartlett, J M S
Publicado 2008

Silent venous thromboembolism before treatment in endometrial cancer and the risk factors

por Satoh, T, Matsumoto, K, Uno, K, Sakurai, M, Okada, S, Onuki, M, Minaguchi, T, Tanaka, Y O, Homma, S, Oki, A, Yoshikawa, H
Publicado 2008

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

por Paré, L, Marcuello, E, Altés, A, Río, E del, Sedano, L, Salazar, J, Cortés, A, Barnadas, A, Baiget, M
Publicado 2008

Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma

por Rand, V, Prebble, E, Ridley, L, Howard, M, Wei, W, Brundler, M-A, Fee, B E, Riggins, G J, Coyle, B, Grundy, R G
Publicado 2008

Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: resu...

por Lorenzen, S, Brücher, B, Zimmermann, F, Geinitz, H, Riera, J, Schuster, T, Roethling, N, Höfler, H, Ott, K, Peschel, C, Siewert, J R, Molls, M, Lordick, F
Publicado 2008

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group

por De Bernardi, B, Mosseri, V, Rubie, H, Castel, V, Foot, A, Ladenstein, R, Laureys, G, Beck-Popovic, M, de Lacerda, A F, Pearson, A D J, De Kraker, J, Ambros, P F, de Rycke, Y, Conte, M, Bruzzi, P, Michon, J
Publicado 2008

Endometrial stromal sarcoma: a population-based analysis

por Chan, J K, Kawar, N M, Shin, J Y, Osann, K, Chen, L-m, Powell, C B, Kapp, D S
Publicado 2008

Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients

por Rouits, E, Charasson, V, Pétain, A, Boisdron-Celle, M, Delord, J-P, Fonck, M, Laurand, A, Poirier, A-L, Morel, A, Chatelut, E, Robert, J, Gamelin, E
Publicado 2008

GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group

por Kweekel, D M, Koopman, M, Antonini, N F, Van der Straaten, T, Nortier, J W R, Gelderblom, H, Punt, C J A, Guchelaar, H-J
Publicado 2008

NEAT: National Epirubicin Adjuvant Trial – toxicity, delivered dose intensity and quality of life

por Earl, H M, Hiller, L, Dunn, J A, Bathers, S, Harvey, P, Stanley, A, Grieve, R J, Agrawal, R K, Fernando, I N, Brunt, A M, McAdam, K, O'Reilly, S, Rea, D W, Spooner, D, Poole, C J
Publicado 2008

Case–control study and meta-analysis of SULT1A1 Arg(213)His polymorphism for gene, ethnicity and environment interaction for cancer risk

por Kotnis, A, Kannan, S, Sarin, R, Mulherkar, R
Publicado 2008

The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer

por Parsons, M F C, Foster, P A, Chander, S K, Jhalli, R, Newman, S P, Leese, M P, Potter, B V L, Purohit, A, Reed, M J
Publicado 2008

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer

por Conroy, T, Viret, F, François, E, Seitz, J F, Boige, V, Ducreux, M, Ychou, M, Metges, J P, Giovannini, M, Yataghene, Y, Peiffert, D
Publicado 2008